Loading...
Serum MicroRNA-191-5p levels in vascular complications of type 1 diabetes: The EURODIAB prospective complications study
Bellini,S. Guarrera,S. Matullo,G. Schalkwijk,C.G. Stehouwer,C.D. Chaturvedi,N. Soedamah-Muthu,S.S. Barutta,F. Gruden,G.
Bellini,S.
Guarrera,S.
Matullo,G.
Schalkwijk,C.G.
Stehouwer,C.D.
Chaturvedi,N.
Soedamah-Muthu,S.S.
Barutta,F.
Gruden,G.
Abstract
Context MicroRNA-191-5p regulates key cellular processes involved in the pathogenesis of diabetic complications such as angiogenesis, extracellular matrix deposition, and inflammation. However, no data on circulating microRNA-191-5p in the chronic complications of diabetes are available.. Objective To assess whether serum levels of microRNA-191-5p were associated with micro- and macrovascular disease in a large cohort of subjects with type 1 diabetes mellitus (DM1) from the EURODIAB Prospective Complication Study. Design and Setting Levels of microRNA-191-5p were measured by quantitative PCR in 420 patients with DM1 recruited as part of the crosssectional analysis of the EURODIAB Prospective Complication Study. Cases (n = 277) were subjects with nephropathy and/or retinopathy and/or cardiovascular disease (CVD). Controls (n = 143) were patients without complications. Logistic regression analysis was performed to evaluate the potential independent association of microRNA-191-5p levels with chronic complications of diabetes. Results Levels of microRNA-191-5p were significantly reduced (P < .001) in cases compared with controls even after adjustment for age, sex, and diabetes duration. Logistic regression analysis revealed that microRNA-191-5p was negatively associated with a 58% reduced odds ratio (OR) of chronic diabetes complications, specifically CVD, micro-macroalbuminuria, and retinopathy (OR, 0.42; 95% CI, 0.23-0.77), independent of age, sex, physical activity, educational levels, diabetes duration, glycated hemoglobin, total insulin dose, hypertension, smoking, total cholesterol, albumin excretion rate, estimated glomerular filtration rate, serum vascular cell adhesion molecule-1, and tumor necrosis factor-α. Analyses performed separately for each complication demonstrated a significant independent association with albuminuria (OR, 0.36; 95% CI, (0.18- 0.75) and CVD (OR, 0.34; 95% CI, 0.16-0.70). Conclusions In DM1 subjects, microRNA-191-5p is inversely associated with vascular chronic complications of diabetes.
Description
Date
2023
Journal Title
Journal ISSN
Volume Title
Publisher
Research Projects
Organizational Units
Journal Issue
Keywords
Albuminuria/etiology, Cardiovascular Diseases/epidemiology, Cross-Sectional Studies, Diabetes Complications, Diabetes Mellitus, Type 1/complications, Diabetic Angiopathies/etiology, Diabetic Retinopathy/etiology, Humans, MicroRNAs, Prospective Studies, Retinal Diseases/complications, Risk Factors, SDG 3 - Good Health and Well-being
Citation
Bellini, S, Guarrera, S, Matullo, G, Schalkwijk, C G, Stehouwer, C D, Chaturvedi, N, Soedamah-Muthu, S S, Barutta, F & Gruden, G 2023, 'Serum MicroRNA-191-5p levels in vascular complications of type 1 diabetes : The EURODIAB prospective complications study', Journal of Clinical Endocrinology and Metabolism, vol. 109, no. 1, dgad468, pp. e163-e174. https://doi.org/10.1210/clinem/dgad468
License
info:eu-repo/semantics/openAccess